Trivant Custom Portfolio Group LLC Decreases Holdings in JPMorgan Chase & Co. (NYSE:JPM)

Trivant Custom Portfolio Group LLC decreased its holdings in JPMorgan Chase & Co. (NYSE:JPMFree Report) by 1.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,199 shares of the financial services provider’s stock after selling 287 shares during the period. JPMorgan Chase & Co. makes up about 2.3% of Trivant Custom Portfolio Group LLC’s holdings, making the stock its 14th biggest holding. Trivant Custom Portfolio Group LLC’s holdings in JPMorgan Chase & Co. were worth $3,883,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in JPM. Mizuho Securities Co. Ltd. purchased a new position in shares of JPMorgan Chase & Co. in the third quarter valued at about $25,000. Catalyst Capital Advisors LLC bought a new stake in JPMorgan Chase & Co. in the third quarter valued at $27,000. Fairway Wealth LLC purchased a new position in shares of JPMorgan Chase & Co. during the second quarter valued at about $32,000. West Financial Advisors LLC bought a new position in JPMorgan Chase & Co. in the third quarter worth about $37,000. Finally, New England Capital Financial Advisors LLC raised its stake in JPMorgan Chase & Co. by 38.5% in the third quarter. New England Capital Financial Advisors LLC now owns 180 shares of the financial services provider’s stock worth $38,000 after buying an additional 50 shares in the last quarter. Institutional investors own 71.55% of the company’s stock.

Insider Buying and Selling

In related news, General Counsel Stacey Friedman sold 3,303 shares of JPMorgan Chase & Co. stock in a transaction that occurred on Thursday, January 16th. The shares were sold at an average price of $253.94, for a total value of $838,763.82. Following the completion of the transaction, the general counsel now owns 47,620 shares in the company, valued at $12,092,622.80. The trade was a 6.49 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.79% of the stock is currently owned by insiders.

JPMorgan Chase & Co. Stock Up 2.0 %

Shares of NYSE:JPM opened at $259.46 on Monday. The company has a market capitalization of $730.47 billion, a price-to-earnings ratio of 14.44, a PEG ratio of 3.16 and a beta of 1.11. JPMorgan Chase & Co. has a 12-month low of $165.24 and a 12-month high of $260.62. The business has a 50-day moving average price of $243.50 and a 200 day moving average price of $224.41. The company has a current ratio of 0.89, a quick ratio of 0.89 and a debt-to-equity ratio of 1.27.

JPMorgan Chase & Co. (NYSE:JPMGet Free Report) last released its quarterly earnings results on Wednesday, January 15th. The financial services provider reported $4.81 EPS for the quarter, topping analysts’ consensus estimates of $4.03 by $0.78. The company had revenue of $42.77 billion for the quarter, compared to analysts’ expectations of $41.90 billion. JPMorgan Chase & Co. had a return on equity of 16.71% and a net margin of 19.64%. The firm’s revenue was up 10.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.04 earnings per share. Sell-side analysts expect that JPMorgan Chase & Co. will post 17.46 EPS for the current year.

JPMorgan Chase & Co. Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Monday, January 6th will be issued a $1.25 dividend. The ex-dividend date is Monday, January 6th. This represents a $5.00 dividend on an annualized basis and a yield of 1.93%. JPMorgan Chase & Co.’s dividend payout ratio (DPR) is presently 27.82%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. Daiwa Capital Markets decreased their target price on JPMorgan Chase & Co. from $240.00 to $235.00 and set an “overweight” rating for the company in a research report on Thursday, October 10th. Robert W. Baird lowered JPMorgan Chase & Co. from a “neutral” rating to an “underperform” rating and set a $200.00 price objective for the company. in a research report on Thursday, November 7th. Piper Sandler upped their target price on shares of JPMorgan Chase & Co. from $240.00 to $275.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 3rd. Wolfe Research raised shares of JPMorgan Chase & Co. from a “peer perform” rating to an “outperform” rating and set a $269.00 price target for the company in a research report on Friday, January 3rd. Finally, Baird R W lowered shares of JPMorgan Chase & Co. from a “hold” rating to a “strong sell” rating in a research note on Thursday, November 7th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, JPMorgan Chase & Co. has a consensus rating of “Hold” and a consensus price target of $251.78.

Read Our Latest Research Report on JPM

About JPMorgan Chase & Co.

(Free Report)

JPMorgan Chase & Co operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking (CCB), Corporate & Investment Bank (CIB), Commercial Banking (CB), and Asset & Wealth Management (AWM). The CCB segment offers deposit, investment and lending products, cash management, and payments and services; mortgage origination and servicing activities; residential mortgages and home equity loans; and credit cards, auto loans, leases, and travel services to consumers and small businesses through bank branches, ATMs, and digital and telephone banking.

Read More

Institutional Ownership by Quarter for JPMorgan Chase & Co. (NYSE:JPM)

Receive News & Ratings for JPMorgan Chase & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan Chase & Co. and related companies with MarketBeat.com's FREE daily email newsletter.